Daxor (DXR) vs Precision Optics (POCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Precision Optics (POCI) has outperformed Daxor (DXR) over the past year, gaining 7.2% versus a loss of 20.0%. Over five years, DXR leads with a -7.0% price change compared with -29.3% for POCI. Daxor is the larger company by market cap ($61.1 million vs $51.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | POCI |
|---|---|---|
| Share price | $10.46 | $4.67 |
| Market cap | $61.07M | $51.19M |
| 1-day change | +1.01% | +3.21% |
| YTD return | -29.08% | +11.34% |
| 1-year return | -20.03% | +7.24% |
| 5-year return | -7.02% | -29.32% |
| P/E ratio (TTM) | 9.51 | — |
| Forward P/E | — | 155.50 |
| EPS (TTM) | $1.10 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $6.15 |
| 52-week low | $8.56 | $3.55 |
| Distance from 52-week high | -29.13% | -24.15% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +91.20% | +71.49% |
| Average volume | 17.27K | 51.88K |
| Shares outstanding | 5.84M | 10.97M |
| Employees | — | 108 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- POCI has outperformed DXR by 27.3 percentage points over the past year.
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About Precision Optics
POCI stock →Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 108 employees
DXR vs POCI FAQ
Which is bigger, Daxor or Precision Optics?
Daxor (DXR) is larger, with a market capitalization of $61.07M compared with $51.19M for Precision Optics (POCI).
Which stock has performed better over the past year, DXR or POCI?
POCI returned +7.24% over the past 12 months, compared with -20.03% for DXR (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and Precision Optics in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Daxor and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Precision Optics.